INS and metabolic dysfunction-associated steatotic liver disease: The presence of estrogen helps to increase tissue sensitivity to insulin and further promotes the oxidation of free fatty acids in the liver, the secretion of VLDL, and the deposition of fat in subcutaneous tissue, inhibiting the deposition of lipids in the liver and achieving the purpose of preventing the occurrence of NAFLD (27, 52).